Acyclic retinoid activates retinoic acid receptor β and induces transcriptional activation of p21CIP1 in HepG2 human hepatoma cells

Molecular Cancer Therapeutics

Volumn 3, Issue 3, 2004, Pages 309-316

  Suzui, Masumi ^a,b   Shimizu, Masahito ^a   Masuda, Muneyuki ^a   Lim, Jin T E ^a   Yoshimi, Naoki ^b   Weinstein, I Bernard ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; CHLORAMPHENICOL ACETYLTRANSFERASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P21; PROTEIN P53; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID; RETINOL;

ARTICLE; ASSAY; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; EXPRESSION VECTOR; GENE INDUCTION; GENETIC TRANSFECTION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA PRIMERS; GENES, REPORTER; HUMANS; MODELS, CHEMICAL; POLYMERASE CHAIN REACTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRETINOIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 4444344411     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Thaller C, Eichele G. Identification and spatial distribution of retinoids in the developing chick limb bud. Nature, 1987;327:625-8.
2. Sporn ME, Suh N. Chemoprevention of cancer. Carcinogenesis, 2000; 21:525-30.
3. Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nat Rev Cancer, 2001;1:181-93.
4. Muto Y, Moriwaki H, Saito A. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. N Engl J Med, 1999;340:1046-7.
5. Muto Y, Moriwaki H, Ninomiya M, et al. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. N Engl J Med, 1996;334:1561-7.
6. Muto Y, Moriwaki H. Antitumor activity of vitamin A and its derivatives. J Natl Cancer Inst, 1984;73:1389-93.
7. Nakamura N, Shidoji Y, Yamada Y, Hatakeyama H, Moriwaki H, Muto Y. Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, Huh-7. Biochem Biophys Res Commun, 1995;207:382-8.
8. CIP1 and inhibition of expression of cyclin D1. Cancer Res, 2002;62:3997-4006.
9. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell, 1995;83:841-50.
10. Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature, 1987; 330:444-50.
11. Wirtanen L, Seguin C. Cloning of cDNAs encoding retinoic acid receptors RARγ1, RARγ2, and a new splicing variant, RARγ3, from Ambystoma mexicanum and characterization of their expression during early development. Biochim Biophys Acta, 2000; 1492:81-93.
12. Chambon PA. A decade of molecular biology of retinoic acid receptors. FASEB J, 1996;10:940-54.
13. Mangelsdorf DJ, Umesono K, Kliewer SA, Borgmeyer U, Ong ES, Evans RM. A direct repeat in the cellular retinoid-binding protein type II gene confers differential regulation by RXR and RAR. Cell, 1991;66:555-61.
14. Lotan R, Xu XC, Lippman SM, et al. Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med, 1995;332:1405-10.
15. Crowe DL, Hu L, Gudas LJ, Rheinwald JG. Variable expression of retinoic acid receptor (RAR-β) mRNA in human oral and epidermal keratinocytes: relation to keratin 19 expression and keratinization potential. Differentiation, 1991;48:199-208.
16. Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res, 1991;51: 3972-81.
17. Zou C, Clifford JL, Xu XC, et al. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Cancer Res, 1994;54:5479-87.
18. Xu XC, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R. Differential expression of nuclear retinoic acid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res, 1994;54:3580-7.
19. The Hd, Marchio A, Tiollais P, Dejean A. Differential expression and ligand regulation of the retinoic acid receptor α and β genes. EMBO J, 1989;8:429-33.
20. Fanjul AN, Delia D, Pierotti MA, Rideout D, Qiu J, Pfahl M. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J Biol Chem, 1996;271:22441-6.
21. Song JI, Lango MN, Hwang JD, et al. Abrogation of transforming growth factor-α/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, targretin) in head and neck cancer cell lines. Cancer Res, 2001;61:5919-25.
22. Weinstein IB. Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis, 2000;21:857-64.
23. Liu M, Iavarone A, Freedman, P. Transcriptional activation of the human p21WAF1/CIP1 gene by retinoic acid receptor. J Biol Chem, 1996; 271:31723-8.
24. Steinman RA, Hofmann B, Iro A, Guillouf C, Liebermann DA, El-Houseini M. Induction of p21 (WAF1/CIP1) during differentiation. Oncogene, 1994;9:3389-96.
25. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature, 1979;282:615-6.
26. Gartel AL, Tyner AL. The growth-regulatory role of p21(WAF1/CIP1). Prog Mal Subcell Biol, 1998;20:43-71.
27. Muller M, Strand S, Hug H, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest, 1997;99:403-13.
28. Hoffman AD, Engelstein D, Bogenrieder T, et al. Expression of retinoic acid receptor β in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid. Clin Cancer Res, 1996;2:1077-82.
29. Levin AA, Sturzenbecker LJ, Kazmer S, et al. 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature, 1992;355:359-61.
30. Heyman RA, Mangelsdorf DJ, Dyck JA, et al. 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 1992;68:397-406.
31. Lotan R. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers. Anticancer Res, 1996;16:2415-9.
32. Lotan R. Suppression of squamous cell carcinoma growth and differentiation by retinoids. Cancer Res, 1994;54(7 Suppl):1987s-90s.
33. Boyle JO, Langenfeld J, Lonardo F, et al. Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells. J Natl Cancer Inst, 1999;91:373-9.
34. Wan H, Oridate N, Lotan D, Hong WK, Lotan R. Overexpression of retinoic acid receptor β in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids. Cancer Res, 1999;59:3518-26.
35. Yamada Y, Shidoji Y, Fukutomi Y, et al. Positive and negative regulations of albumin gene expression by retinoids in human hepatoma cell lines. Mol Carcinog, 1994;10:151-8.
36. Chen JY, Penco S, Ostrowski J, et al. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J, 1995;14: 1187-97.
37. Lin F, Xiao D, Kolluri SK, Zhang, X. Unique anti-activator protein-1 activity of retinoic acid receptor β. Cancer Res, 2000;60:3271-80.
38. Frangioni JV, Moghal N, Stuart-Tilley A, Neel BG, Alper SL. The DNA binding domain of retinoic acid receptor β is required for ligand-dependent suppression of proliferation. J Cell Sci, 1994;107:827-38.
39. Si SP, Lee XL, Tsou HC, Buchsbaum R, Tibaduiza E, Peacoke M. RARβ2-mediated growth inhibition in HeLa cells. Exp Cell Res, 1996; 223:102-11.
40. Van der Leede B-J, Opdenoordt T, Van den Brink CE, Ebert T, Van der Saag PT. Implication of retinoic acid receptor β in renal cell carcinoma. Int J Oncol, 1995;6:391-400.
41. Liu Y, Lee MO, Wang HG, et al. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol, 1996;16:1138-49.
42. Li XS, Shao Z-M, Sheikh MS, et al. Retinoic acid receptor β inhibits breast carcinoma anchorage-independent growth. J Cell Physiol, 1995; 165:449-58.
43. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K. Expression of RARβ mediates RA-induced growth arrest and apoptosis in breast cancer cells. Cell Growth & Differ, 1995;6:1077-88.
44. Oridate N, Esumi N, Lotan D, et al, Implication of retinoic acid receptor γ in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells. Oncogene, 1996; 12:2019-28.
45. van der Leede BM, van den Brink CE, van der Saag PT. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines. Mol Carcinog, 1993;8:112-22.
46. Jiang H, Lin J, Su Z-z, Collart FR, Huberman E, Fisher PB. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 1994; 9:3397-406.
47. Naka K, Yokozaki H, Doman T, et al. Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein. Differentiation, 1997;61:313-20.
48. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene, 1995;11:493-504.
49. Antoun GR, Re GG, Terry NH, Zipf TF. Molecular genetic evidence for a differentiation-proliferation coupling during DMSO-induced myeloid maturation of HL-60 cells: role of the transcription elongation block in the c-myc gene. Leukemia Res, 1991;15:1029-36.
50. Hsu S-L, Lin Y-F, Chou C-K. Transcriptional regulation of transferrin and albumin genes by retinoic acid in human hepatoma cell fine Hep3B. Biochem J, 1992;283:611-5.
51. Frankel SR, Eardley A, Lauwers G, Weiss M, Warrel RP Jr. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Int Med, 1992;117:292-6.
52. Silverman AK, Ellis CN, Voorhees JJ. Hypervitaminosis A syndrome: a paradigm of retinoid side effects. J Am Acad Dermatol, 1987;16: 1027-39.